Go to the list of all blogs
published in Blogs
Sep 18, 2026
ESAB Corporation (ESAB) Stock Slides -15.5% in 30 Days as Margins and Leverage Concerns Mount

ESAB Corporation (ESAB) Stock Slides -15.5% in 30 Days as Margins and Leverage Concerns Mount

Key Takeaways

  • ESAB shares declined roughly 15.5% over the trailing 30 days, falling from $78.89 to $66.67.
  • The drop extends a steeper slide of about 37% over the trailing three-month period, leaving the stock well below its 52-week high near $137.
  • Second-quarter revenue beat expectations at $807.6 million (up 12.9% year over year), but adjusted EPS of $1.33 missed consensus and operating margin compressed sharply.
  • The early closing of the $1.45 billion Eddyfi acquisition raised leverage concerns even as management lifted its full-year 2026 guidance.
  • Analysts still hold a "Moderate Buy" consensus with an average target near $138, while macroeconomic and tariff-related pressures weigh on near-term sentiment.

Company Background and Competitive Landscape

ESAB Corporation is a global manufacturer of welding, cutting, and gas control equipment, consumables, and automation solutions. Founded in 1904 and spun off from Colfax in 2022, the company serves construction, shipbuilding, energy, infrastructure, automotive, and general manufacturing end markets through its Americas and EMEA & APAC segments. Its portfolio spans welding power sources, cutting machines, torches, electrodes, filler metals, and robotic and automated fabrication systems.

The company ranks among the leading players in welding technology, competing primarily with Lincoln Electric and the Miller brand of Illinois Tool Works. Investors follow ESAB closely for its shift toward higher-margin equipment and automation, its exposure to emerging markets such as India and the Middle East, and its disciplined acquisition strategy. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Price Performance: 30 Days and the Broader Quarter

Over the last 30 days, ESAB shares moved from a closing price of $78.89 to $66.67, a decline of approximately 15.5%. The move was punctuated by a series of new 52-week lows in late August and September, with the stock trading beneath both its 50-day and 200-day moving averages.

The weakness is part of a broader trend. Measured from a mid-June closing level near $106, the stock has fallen roughly 37% over the trailing three-month period. The shares are now down more than 50% from their 52-week high of $137.42, reflecting a sustained re-rating of the stock's valuation multiples even as reported revenue has continued to grow. From what I see, this re-rating stands out given the underlying sales momentum.

Key Drivers Behind the 30-Day Move

The most consequential catalyst was the company's second-quarter report, released in early August. While revenue of $807.6 million beat consensus estimates and rose 12.9% year over year, adjusted earnings per share of $1.33 missed analysts' expectations by $0.04. Net income fell to $32.35 million from $66.88 million a year earlier, and operating margin contracted to 9.7% from 15.2%, raising concerns about profitability even as sales expanded.

Compounding the earnings miss, the early completion of the Eddyfi acquisition increased investor focus on the balance sheet. The transaction pushed pro forma net debt higher and raised leverage to roughly 3.3 times EBITDA, prompting analysts to highlight deleveraging as a near-term risk. Insider selling, reported at about $8.9 million over the prior twelve months, added to the cautious tone. I’m watching this closely as macroeconomic factors also contributed, including tariff-related uncertainty, rerouted logistics and higher freight costs tied to Middle East disruptions, and broader industrial-sector deleveraging.

Drivers of the Three-Month Decline

The three-month decline reflects a shift in the market's emphasis from top-line growth to earnings quality and leverage. Earlier in the year, ESAB reported record first-quarter sales of $715 million and reaffirmed its outlook, supported by strong bookings and pricing actions. However, persistent margin compression, tariff headwinds, and the dilutive early phases of the Eddyfi integration gradually eroded confidence.

Management's decision to raise full-year 2026 guidance following the Eddyfi close, including adjusted EPS of $5.40 to $5.50 and adjusted EBITDA of $615 million to $625 million, was not enough to offset concerns that near-term profitability would remain under pressure. As the quarter progressed, the stock repeatedly set new lows, underscoring how cyclical, trade, and integration risks have come to dominate the narrative over shorter-term fundamentals.

What to Watch Going Forward

Looking ahead, investors will be watching whether ESAB can convert record sales growth into margin recovery. The integration and deleveraging timeline following the Eddyfi acquisition remains a central focus, as does the company's progress toward its raised 2026 adjusted EBITDA and EPS targets. Upcoming quarterly results will provide an early read on whether price-cost pressures, logistics costs, and tariff-related volume headwinds are stabilizing. In my view, demand trends in key end markets, including energy, infrastructure, and industrial automation, along with the pace of recovery in emerging markets, will also shape sentiment. Any changes to analyst ratings or price targets, and the broader direction of industrial-sector valuations, may influence the stock's path. These factors should be evaluated as part of a broader investment review rather than as standalone signals.

Using AI Tools in My Research Process

When analyzing stocks like this, I often rely on Tickeron’s AI Daily Buy/Sell Signals to get a quick read on momentum and potential entry or exit points alongside traditional fundamentals. The platform helps surface patterns that might otherwise go unnoticed in volatile industrial names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ESAB

ESAB's Indicator enters downward trend

The Aroon Indicator for ESAB entered a downward trend on September 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 146 similar instances where the Aroon Indicator formed such a pattern. In 97 of the 146 cases the stock moved lower. This puts the odds of a downward move at 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ESAB turned negative on August 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 24 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESAB advanced for three days, in 196 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

ESAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.746) is normal, around the industry mean (3.163). P/E Ratio (20.840) is within average values for comparable stocks, (31.021). Projected Growth (PEG Ratio) (0.650) is also within normal values, averaging (0.846). Dividend Yield (0.006) settles around the average of (0.015) among similar stocks. P/S Ratio (1.358) is also within normal values, averaging (5901.087).

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ESAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

Industry description

The industry is involved in value-added processes including creation of metal structures like machines and parts by cutting, bending and assembling, using various raw materials. A fabrication shop often bids on a project/job, and then builds the product if awarded the contract. Robotics and automation are making their way into the industry apparently to fill in skills gap[s19] . RBC Bearings Incorporated, Timken Company and Valmont Industries, Inc. are some of the largest metal fabrication companies in the U.S.

Market Cap

The average market capitalization across the Metal Fabrication Industry is 4.56B. The market cap for tickers in the group ranges from 723 to 56.71B. MEKTF holds the highest valuation in this group at 56.71B. The lowest valued company is BDGY at 723.

High and low price notable news

The average weekly price growth across all stocks in the Metal Fabrication Industry was -2%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was 8%. PRLB experienced the highest price growth at 8%, while CRS experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Metal Fabrication Industry was 31%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -78%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 56
Price Growth Rating: 60
SMR Rating: 76
Profit Risk Rating: 73
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
ESAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MetalFabrication

Profile
Details
Industry
N/A
Address
909 Rose Avenue
Phone
+1 301 323-9099
Employees
10300
Web
https://www.esabcorporation.com
Interact to see
Advertisement
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
ESAB Corporation (ESAB) Stock Slides -15.5% in 30 Days as Margins and Leverage Concerns Mount